TY - JOUR
T1 - Allergen immunotherapy in children and adolescents with respiratory diseases
AU - Tosca, Maria Angela
AU - Licari, Amelia
AU - Olcese, Roberta
AU - Castagnoli, Riccardo
AU - Marseglia, Alessia
AU - Marseglia, Gian Luigi
AU - Del Giudice, Michele Miraglia
AU - Martelli, Alberto
AU - Calvani, Mauro
AU - Caffarelli, Carlo
AU - Duse, Marzia
AU - Cravidi, Claudio
AU - Cardinale, Fabio
AU - Ciprandi, Giorgio
PY - 2020
Y1 - 2020
N2 - To date, the only disease-modifying treatment strategy for allergic rhinitis and asthma is allergen immunotherapy (AIT). There is evidence that AIT improves allergic rhinitis and asthma, such as reducing symptom severity and medication use and improving of quality of life, with a long-lasting effect after the end of the course. The recent clinical trials evidenced AIT effectiveness and safety in allergic asthma. Consequently, the current version of the GINA (Global Initiative for Asthma) guidelines recommend AIT as an add-on therapy for asthma. There is also evidence that AIT may exert preventive activity on the possible progression from allergic rhinitis to asthma in children and the onset of new sensitizations. (www.actabiomedica.it).
AB - To date, the only disease-modifying treatment strategy for allergic rhinitis and asthma is allergen immunotherapy (AIT). There is evidence that AIT improves allergic rhinitis and asthma, such as reducing symptom severity and medication use and improving of quality of life, with a long-lasting effect after the end of the course. The recent clinical trials evidenced AIT effectiveness and safety in allergic asthma. Consequently, the current version of the GINA (Global Initiative for Asthma) guidelines recommend AIT as an add-on therapy for asthma. There is also evidence that AIT may exert preventive activity on the possible progression from allergic rhinitis to asthma in children and the onset of new sensitizations. (www.actabiomedica.it).
KW - Allergen-specific immunotherapy
KW - Allergic asthma
KW - Children
KW - Subcutaneous immunotherapy
KW - Sublingual immunotherapy
UR - http://www.scopus.com/inward/record.url?scp=85092356275&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092356275&partnerID=8YFLogxK
U2 - 10.23750/abm.v91i11-S.10309
DO - 10.23750/abm.v91i11-S.10309
M3 - Review article
AN - SCOPUS:85092356275
VL - 91
SP - 1
EP - 4
JO - Acta Biomedica de l'Ateneo Parmense
JF - Acta Biomedica de l'Ateneo Parmense
SN - 0392-4203
M1 - e2020006
ER -